Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease. / Kelly, Benjamin; Mohanakumar, Sheyanth; Hjortdal, Vibeke Elisabeth.

I: Current Cardiology Reports, Bind 22, Nr. 12, 164, 10.10.2020.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Kelly, B, Mohanakumar, S & Hjortdal, VE 2020, 'Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease', Current Cardiology Reports, bind 22, nr. 12, 164. https://doi.org/10.1007/s11886-020-01405-y

APA

Kelly, B., Mohanakumar, S., & Hjortdal, V. E. (2020). Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease. Current Cardiology Reports, 22(12), [164]. https://doi.org/10.1007/s11886-020-01405-y

Vancouver

Kelly B, Mohanakumar S, Hjortdal VE. Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease. Current Cardiology Reports. 2020 okt. 10;22(12). 164. https://doi.org/10.1007/s11886-020-01405-y

Author

Kelly, Benjamin ; Mohanakumar, Sheyanth ; Hjortdal, Vibeke Elisabeth. / Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease. I: Current Cardiology Reports. 2020 ; Bind 22, Nr. 12.

Bibtex

@article{6d8802c5012c42a297e4c5bec330b4b9,
title = "Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease",
abstract = "PURPOSE OF REVIEW: Lymphatic disorders have received an increasing amount of attention over the last decade. Sparked primarily by improved imaging modalities and the dawn of lymphatic interventions, understanding, diagnostics, and treatment of lymphatic complications have undergone considerable improvements. Thus, the current review aims to summarize understanding, diagnostics, and treatment of lymphatic complications in individuals with congenital heart disease.RECENT FINDINGS: The altered hemodynamics of individuals with congenital heart disease has been found to profoundly affect morphology and function of the lymphatic system, rendering this population especially prone to the development of lymphatic complications such as chylous and serous effusions, protein-losing enteropathy and plastic bronchitis. Although improved, a full understanding of the pathophysiology and targeted treatment for lymphatic complications is still wanting. Future research into pharmacological improvement of lymphatic function and continued implementation of lymphatic imaging and interventions may improve knowledge, treatment options, and outcome for affected individuals.",
author = "Benjamin Kelly and Sheyanth Mohanakumar and Hjortdal, {Vibeke Elisabeth}",
year = "2020",
month = oct,
day = "10",
doi = "10.1007/s11886-020-01405-y",
language = "English",
volume = "22",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Springer",
number = "12",

}

RIS

TY - JOUR

T1 - Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease

AU - Kelly, Benjamin

AU - Mohanakumar, Sheyanth

AU - Hjortdal, Vibeke Elisabeth

PY - 2020/10/10

Y1 - 2020/10/10

N2 - PURPOSE OF REVIEW: Lymphatic disorders have received an increasing amount of attention over the last decade. Sparked primarily by improved imaging modalities and the dawn of lymphatic interventions, understanding, diagnostics, and treatment of lymphatic complications have undergone considerable improvements. Thus, the current review aims to summarize understanding, diagnostics, and treatment of lymphatic complications in individuals with congenital heart disease.RECENT FINDINGS: The altered hemodynamics of individuals with congenital heart disease has been found to profoundly affect morphology and function of the lymphatic system, rendering this population especially prone to the development of lymphatic complications such as chylous and serous effusions, protein-losing enteropathy and plastic bronchitis. Although improved, a full understanding of the pathophysiology and targeted treatment for lymphatic complications is still wanting. Future research into pharmacological improvement of lymphatic function and continued implementation of lymphatic imaging and interventions may improve knowledge, treatment options, and outcome for affected individuals.

AB - PURPOSE OF REVIEW: Lymphatic disorders have received an increasing amount of attention over the last decade. Sparked primarily by improved imaging modalities and the dawn of lymphatic interventions, understanding, diagnostics, and treatment of lymphatic complications have undergone considerable improvements. Thus, the current review aims to summarize understanding, diagnostics, and treatment of lymphatic complications in individuals with congenital heart disease.RECENT FINDINGS: The altered hemodynamics of individuals with congenital heart disease has been found to profoundly affect morphology and function of the lymphatic system, rendering this population especially prone to the development of lymphatic complications such as chylous and serous effusions, protein-losing enteropathy and plastic bronchitis. Although improved, a full understanding of the pathophysiology and targeted treatment for lymphatic complications is still wanting. Future research into pharmacological improvement of lymphatic function and continued implementation of lymphatic imaging and interventions may improve knowledge, treatment options, and outcome for affected individuals.

U2 - 10.1007/s11886-020-01405-y

DO - 10.1007/s11886-020-01405-y

M3 - Review

C2 - 33037935

VL - 22

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 12

M1 - 164

ER -

ID: 250598499